These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29590750)

  • 1. Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.
    Giroud M; Dietzel U; Anselm L; Banner D; Kuglstatter A; Benz J; Blanc JB; Gaufreteau D; Liu H; Lin X; Stich A; Kuhn B; Schuler F; Kaiser M; Brun R; Schirmeister T; Kisker C; Diederich F; Haap W
    J Med Chem; 2018 Apr; 61(8):3350-3369. PubMed ID: 29590750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2 H-1,2,3-Triazole-Based Dipeptidyl Nitriles: Potent, Selective, and Trypanocidal Rhodesain Inhibitors by Structure-Based Design.
    Giroud M; Kuhn B; Saint-Auret S; Kuratli C; Martin RE; Schuler F; Diederich F; Kaiser M; Brun R; Schirmeister T; Haap W
    J Med Chem; 2018 Apr; 61(8):3370-3388. PubMed ID: 29590751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
    McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.
    Maiorana S; Ettari R; Previti S; Amendola G; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M
    ChemMedChem; 2020 Aug; 15(16):1552-1561. PubMed ID: 32567172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Ettari R; Tamborini L; Angelo IC; Micale N; Pinto A; De Micheli C; Conti P
    J Med Chem; 2013 Jul; 56(14):5637-58. PubMed ID: 23611656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
    Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R
    Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L.
    Ehmke V; Winkler E; Banner DW; Haap W; Schweizer WB; Rottmann M; Kaiser M; Freymond C; Schirmeister T; Diederich F
    ChemMedChem; 2013 Jun; 8(6):967-75. PubMed ID: 23658062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R
    ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.
    Massai L; Messori L; Micale N; Schirmeister T; Maes L; Fregona D; Cinellu MA; Gabbiani C
    Biometals; 2017 Apr; 30(2):313-320. PubMed ID: 28283781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.
    Jung S; Fuchs N; Johe P; Wagner A; Diehl E; Yuliani T; Zimmer C; Barthels F; Zimmermann RA; Klein P; Waigel W; Meyr J; Opatz T; Tenzer S; Distler U; Räder HJ; Kersten C; Engels B; Hellmich UA; Klein J; Schirmeister T
    J Med Chem; 2021 Aug; 64(16):12322-12358. PubMed ID: 34378914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action.
    Royo S; Rodríguez S; Schirmeister T; Kesselring J; Kaiser M; González FV
    ChemMedChem; 2015 Sep; 10(9):1484-7. PubMed ID: 26179752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
    Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
    Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole inhibitors of the major cysteine protease of
    Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
    Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
    [No Abstract]   [Full Text] [Related]  

  • 18. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
    Troeberg L; Chen X; Flaherty TM; Morty RE; Cheng M; Hua H; Springer C; McKerrow JH; Kenyon GL; Lonsdale-Eccles JD; Coetzer TH; Cohen FE
    Mol Med; 2000 Aug; 6(8):660-9. PubMed ID: 11055585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M
    J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.
    Schirmeister T; Schmitz J; Jung S; Schmenger T; Krauth-Siegel RL; Gütschow M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):45-50. PubMed ID: 27890381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.